Types and effects of medical weight loss injections (Mounjaro, GLP-1): how they work and how to choose safely, explained by a doctor

  • Published:
  • Updated:
  • Written by the Hiro Clinic Medical Weight Loss editorial team
  • 48 min read
Medically reviewed by Dr. Hiroko Oka Reviewed byDr. Hiroko OkaCertified Member, Japanese Society of Internal Medicine Editorial policy
Types and effects of medical weight loss injections (Mounjaro, GLP-1): how they work and how to choose safely, explained by a doctor

“Medical weight loss,” carried out professionally at medical institutions to maintain a healthy body shape or treat obesity, is attracting attention. When diet therapy and exercise alone do not produce enough weight loss, using medications or injections under a doctor’s supervision may be considered. This article explains the types of injection therapy actually used in medical weight loss, how they work, their safety and their effects. In the consultation room we are often asked, “I don’t know which one is right for me,” so we have summarized the features of each. Please note in advance that all of these treatments are self-pay treatment (not covered by health insurance), and the full cost is borne by the patient.

Key points firstShort on time? Just read this part

  • GLP-1 receptor agonists are an injection therapy given under a doctor’s supervision for appetite suppression and blood sugar control
  • Fat-dissolving injections are an injection therapy that delivers medication directly into areas of concern, aiming for localized fat reduction
  • Injection therapy in medical weight loss is not simply a cosmetic procedure but a treatment based on scientific evidence

1. What is medical weight loss?

Medical weight loss is treatment provided by a doctor based on scientific evidence for people who medically need weight management, such as those with obesity disease or metabolic syndrome.
Unlike general beauty salons and spas, it is characterized by medical diagnosis and testing, and appropriate selection of medication and dosing plans.

Medical weight loss includes several approaches such as oral medication, hormone injections and fat-dissolving injections, and among these, demand is growing for injection therapy as a method that may act on body fat locally or throughout the body, with expected quick onset and high effectiveness.

2. Overview of injection therapies used in medical weight loss

The main injections used in medical weight loss can be classified into the following three types.

  1. GLP-1 receptor agonist injections
  2. Fat-dissolving injections (mesotherapy)
  3. L-carnitine and alpha-lipoic acid injections

Each has a different mechanism of action and indication, so the choice needs to be made according to your constitution and goals.

3. GLP-1 receptor agonist injections

GLP-1 receptor agonists are an injection therapy given under a doctor’s supervision for appetite suppression and blood sugar control.

(1) Overview

GLP-1 (glucagon-like peptide-1) is a hormone originally secreted in the small intestine that promotes insulin secretion after meals.
GLP-1 receptor agonists make use of this action. They were developed mainly as diabetes medications, but strong appetite-suppressing and weight-reducing effects were confirmed, and they are also applied to obesity treatment.

Representative products:

  • Liraglutide (Saxenda®)
  • Semaglutide (Wegovy®)

(2) Mechanism of action

GLP-1 receptor agonists

  • stimulate the satiety center in the brain to reduce appetite
  • delay gastric emptying to prolong the feeling of fullness
  • increase insulin secretion to stabilize blood sugar
    Through these multiple actions, they encourage a natural reduction in food intake.

Reference study: NEJM “Once-Weekly Semaglutide in Adults with Overweight or Obesity”

In this large-scale trial, an average weight loss of about 15% was confirmed after 68 weeks of treatment. However, this is the average among trial participants, and actual effects vary from person to person. On X, too, we saw a post that accurately conveyed the drug’s positioning: “Mounjaro is a type 2 diabetes medication. It is the world’s first long-acting GIP/GLP-1 receptor agonist whose effect lasts with just one self-injection a week” (from a post by @i9_lhx). Although the “weight loss drug” aspect tends to be emphasized, we feel it is important to use it with the understanding that it is fundamentally a therapeutic medication.

(3) Side effects and precautions

  • Gastrointestinal symptoms such as nausea, diarrhea and constipation
  • Hypoglycemia (especially in patients with diabetes)
  • Rare risk of pancreatitis

It must always be given under a doctor’s supervision.

How many months should you continue Mounjaro? A doctor explains the weight-loss period and when to expect results

In short, there is no fixed treatment period for Mounjaro after which “...

4. Fat-dissolving injections (mesotherapy)

Fat-dissolving injections are an injection therapy that delivers medication directly into areas of concern, aiming for localized fat reduction.

(1) Overview

Fat-dissolving injections are a treatment in which medication is injected directly into subcutaneous fat to break down fat cells and have them eliminated.
They are used for spot reduction and improving body contours.

Representative agents:

  • Deoxycholic acid (FDA-approved)
  • Phosphatidylcholine
  • Formulations containing caffeine and carnitine

(2) Mechanism of action

They break down fat cell membranes, and the fat is eliminated from the body through metabolic pathways.
Because the injection site is limited, they are suited to localized slimming of areas such as the face, upper arms and abdomen.

Reference study: PubMed “Early Experience in 100 Consecutive Patients With Injection Adipocytolysis for Neck Contouring With ATX-101 (Deoxycholic Acid)” (Shridharani SM, Dermatol Surg 2017)

This review shows a significant fat-reducing effect of deoxycholic acid injections.

(3) Side effects and precautions

  • Swelling, bruising and pain at the injection site
  • Hardening (induration) due to over-injection
  • Allergic reactions

Swelling lasting about one week after treatment is to be expected.

5. L-carnitine and alpha-lipoic acid injections

L-carnitine and alpha-lipoic acid injections are a supplementary injection therapy focusing on lipid metabolism and antioxidant effects.

(1) Overview

L-carnitine is an amino acid–derived substance that promotes lipid metabolism, and alpha-lipoic acid is a coenzyme with strong antioxidant effects.
Injecting them raises their blood levels, and they are used with the aim of burning fat and improving metabolism.

They are particularly indicated for the following people.

  • People with a lot of visceral fat
  • People whose basal metabolism has declined
  • People with marked feelings of cold or swelling

(2) Mechanism of action

  • Transports fatty acids into mitochondria to convert them into energy
  • Suppresses reactive oxygen species and improves metabolic efficiency

Through these actions, a fat-reducing effect is expected when combined with exercise therapy.

Reference study: PubMed “The Effect of (L-)Carnitine on Weight Loss in Adults: A Systematic Review and Meta-Analysis” (Pooyandjoo M et al., Obesity Reviews 2016)

In this meta-analysis (9 RCTs, 911 participants), significant reductions in body weight and BMI were reported in the L-carnitine supplementation groups compared with control groups. However, the size of the effect varied between studies, and it does not guarantee substantial weight loss on its own.

Note

6. How to choose a medical weight loss injection

The suitability of injection therapy differs depending on your goals and constitution. Please refer to the comparison table below.

Type of injectionScopeMain actionCharacteristic effect
GLP-1 agonistWhole-body weight lossAppetite suppressionLong-term weight loss
Fat-dissolving injectionSpot reductionDestruction of fat cellsLocalized, quick effect
Carnitine injectionBasal metabolismFat burningImproved metabolism

About self-pay treatment and off-label use

Self-pay treatment
Medical weight loss is self-pay treatment (paid in full by the patient) and is not covered by public health insurance.
Off-label use
Using medicines for weight management or weight loss may be off-label use, outside the indications approved in Japan.
Relief System for Adverse Drug Reactions
With off-label use, health damage such as a serious side effect may not be covered by Japan’s Relief System for Adverse Drug Reactions.
Individual differences and the doctor’s judgment
Effects and side effects vary from person to person. A doctor decides after a consultation whether you can use a medicine and which medicine and dose are appropriate. Please tell us in advance about any symptoms, chronic conditions or medicines you are taking.

Frequently asked Q&A

Here are questions about medical weight loss injections that we are often asked during consultations.

QCan I lose weight with medical weight loss injections alone?
A

Some effect can be expected even on their own, but combining them with diet therapy and exercise therapy makes lasting weight loss possible.

QI’m worried about side effects.
A

Medical weight loss is always carried out under a doctor’s supervision, so safety checks and risk management are thorough. Make sure you receive a full explanation before treatment.

QHow soon will I see results?
A

With GLP-1 agonists, weight loss is often seen from around week 4 onward, and with fat-dissolving injections, a reduction in the treated area is often noticed within 1–2 weeks. However, how effects appear varies from person to person.

QIs Mounjaro covered by health insurance?
A

In Japan, Mounjaro is approved as a medication for type 2 diabetes, and its use for weight loss is self-pay treatment not covered by health insurance. The full cost is borne by the patient.

QDo the injections hurt?
A

GLP-1 agonists are self-injected with a fine needle, and devices designed to cause little pain are generally used. However, how pain is felt varies from person to person.

8. Costs and precautions for medical weight loss injections

Costs vary by clinic and medication, but the following are rough guidelines.

  • GLP-1 agonists: ¥30,000–70,000 per month
  • Fat-dissolving injections: ¥10,000–50,000 per area per session
  • Carnitine injections: ¥3,000–10,000 per session

As self-pay treatment, these are not covered by health insurance, and regular clinic visits are required. Make a plan that is manageable for you.

Not sure if it suits you? Start with a consultation.

A doctor decides whether you can use it and which dose is appropriate, based on your consultation and questionnaire.

No consultation fee (first & follow-up visits)Online consultation available

9. Summary so far

Injection therapy in medical weight loss is not simply a cosmetic procedure but a treatment based on scientific evidence. It has a variety of actions, including appetite suppression, localized fat breakdown and promotion of fat burning, and the appropriate option is chosen according to each person’s constitution and goals. Some people call GLP-1 a “weight loss shot,” but others point out that it simply applies the action of a hormone that already exists in the body and is not a magic drug (from a post by @manjaroclinic). We tell patients the same thing in consultations, and we hope they will use it with an understanding of how it works, without excessive expectations.

When carried out within a proper medical care system, high safety and lasting weight loss can be expected. Because how effects appear and the severity of side effects vary from person to person, choosing a treatment that suits you while consulting a specialist leads to manageable weight control.

[Reference studies and evidence links]

10. Clinical use of medical weight loss injections and the flow of treatment

All injection therapies begin only after a consultation and tests at a medical institution.
Here we describe the actual process when considering treatment.

(1) Initial counseling

In a medical interview and examination, the doctor checks the following.

  • Degree of obesity (BMI, visceral fat area)
  • Medical history (diabetes, high blood pressure, history of pancreatitis, etc.)
  • Current eating and exercise habits
  • Expectations of treatment

At this point, we assess “whether injection therapy is suitable.” In actual consultations, taking the medical history alone often takes longer than expected, and we feel that the more carefully we proceed, including aligning expectations for treatment, the higher the satisfaction later on.

(2) Basic tests

For GLP-1 agonists, blood tests are done to check pancreatic, liver and kidney function.
For fat-dissolving injections, the risk of local infection may be checked.

(3) Creating a treatment plan

In medical weight loss, most cases combine multiple treatments rather than a single therapy (injections, diet and exercise).

For example:

  • GLP-1 agonist injection once weekly
  • Fat-dissolving injections 1–2 times per month
  • Dietary guidance from a registered dietitian

—multiple interventions are combined in this way.

(4) Starting injections

For GLP-1 agonists, a nurse typically provides instruction at the clinic at the first dose, after which the patient self-injects at home.
Fat-dissolving injections are administered at the clinic by a doctor or nurse and take about 15–30 minutes.

11. An example case of injection therapy

Because the course of treatment varies greatly from person to person, here we present a generalized version of the course commonly seen in actual practice. It is not the record of a specific patient; please treat it as a general trend.

Many people with chronic conditions such as high blood pressure who feel they have reached the limit of self-directed dieting wish to try medical weight loss. In such cases, it is common to create a combined treatment plan that pairs injection therapy, such as GLP-1 agonists, with diet therapy and exercise therapy.

After starting treatment, many report noticing a change in appetite within a few weeks, with weight gradually decreasing. Some people also see improvements in related metabolic markers such as blood sugar and HbA1c, but how quickly and how much effect appears varies from person to person, and not everyone follows the same course. Mild gastrointestinal symptoms such as nausea may occur early on, but in most cases they are reported to subside within a few days to about a week.

In this way, injection therapy may contribute to medium- to long-term weight control and can also lead to improvement in coexisting conditions. However, effects and side effects vary from person to person, so please ask your doctor directly during your consultation about what to expect in your case.

12. Evidence and clinical trials for each injection

The effectiveness and safety of injection therapies have been examined in many clinical studies. Here is a summary of the main study results.

GLP-1 agonists

STEP 1 trial published in NEJM

  • Participants: adults with obesity or overweight
  • Treatment: semaglutide 2.4 mg subcutaneous injection once weekly
  • Result: average weight loss of 14.9% at 68 weeks
  • Adverse events: gastrointestinal symptoms were the most common

Fat-dissolving injections

US FDA-approved deoxycholic acid injection (Kybella®)

  • Target: reduction of submental (under-chin) fat
  • Studies: multiple RCTs
  • Result: significant reduction in fat thickness after 2–4 treatments
  • Side effects: swelling and induration (1–2 weeks)

L-carnitine injections

Evidence for improved exercise performance and fat burning

  • Significant reductions in body weight and BMI reported in several meta-analyses
  • Results vary; effect is greater when combined with exercise

PubMed: L-Carnitine and Weight Loss(Pooyandjoo 2016)

13. Psychological support for continuing injection therapy

In medical weight loss, psychological support is essential for continuing treatment. The following are particularly helpful.

(1) Self-monitoring

  • Food diary apps
  • Weight graphs
  • Photo records

Using tools like these to regularly experience a “sense of achievement” helps prevent a drop in motivation due to injection side effects or plateaus.

(2) Building up small successes

Rather than fixating only on weight,

  • a smaller waist size
  • appropriate portion sizes
  • establishing an exercise habit
    —we evaluate progress like this along the way.

14. The future of medical weight loss injections

Treatment for obesity disease is advancing year by year, and research into next-generation treatments beyond GLP-1 drugs is also progressing.

GIP/GLP-1 dual agonist (tirzepatide)

  • Developed as a diabetes treatment
  • Greater weight loss effect than GLP-1 alone
  • Approved by the US FDA in 2022
  • Weight loss rate: about 20% (SURMOUNT-1 trial)

Reference: NEJM GIP/GLP-1

In Japan, tirzepatide is approved as the type 2 diabetes medication “Mounjaro,” and a product with the same ingredient for treating obesity disease, “Zepbound,” has also been approved and launched in Japan. Please note that when Mounjaro is used for weight loss in medical weight loss practice, including at our clinic, it is self-pay treatment not covered by health insurance. All figures are averages from overseas clinical trials, and the actual amount of weight lost varies depending on each person’s constitution and lifestyle.

15. Summary

Injection therapy for medical weight loss is a strong, science-based approach to obesity disease and excess weight.

GLP-1 agonists: appetite suppression, improved blood sugar
Fat-dissolving injections: spot reduction, contouring
Carnitine injections: promoting fat burning

By choosing the most suitable treatment for your constitution, goals and lifestyle, sustainable and substantial weight loss can be expected.

Rather than relying only on injections, it is ideal to take a comprehensive approach combining them with improvements in diet, exercise and lifestyle habits.

Start with counseling at a medical institution, and consider the method that suits you together with a specialist.

[References and evidence]

Medically reviewed by: Dr. Hiroko Oka (Chair, Fukubikai Medical Corporation / Certified Member, Japanese Society of Internal Medicine)

Who to contact if you have side effects | When to seek care

If any of the following symptoms occur, please contact us rather than waiting to see on your own. GIP/GLP-1 receptor agonists, including Mounjaro, are known to cause side effects, mainly gastrointestinal symptoms. Most are mild, but serious ones occur in rare cases.

SymptomPossible causeWhat to do
Persistent nausea or vomitingGastrointestinal symptoms; the most common side effectContact us if you continue to be unable to keep fluids down
Severe abdominal pain (pain that radiates to the back)Possible acute pancreatitisStop the medication immediately and seek medical care
Cold sweat, palpitations, intense hunger, feeling confused or drowsyHypoglycemiaTake sugar right away and contact us
Skin rash, difficulty breathing, swelling of the face or throatAllergic reactionSeek medical care immediately

Contact: 0120-241-929 (hours 9:00–18:00)
If your symptoms are severe outside these hours, please go to a nearby emergency medical facility.

Direct phone numbers for each clinic are listed on the clinic information page.

References

The information about medications in this article is based on the following official sources. For details on dosage and administration and side effects, always check the latest electronic package insert.
Pharmaceuticals and Medical Devices Agency (PMDA): “Mounjaro Subcutaneous Injection Ateos, electronic package insert” (Japanese)
PMDA: “Drug Guide for Patients: Mounjaro Subcutaneous Injection Ateos” (PDF, Japanese)
Ministry of Health, Labour and Welfare: “Prevention of lifestyle-related diseases” (Japanese)

When Mounjaro is used for purposes other than obesity disease, it is self-pay treatment and is not covered by public health insurance. Effects and side effects vary from person to person.

Reviewing doctor: Hiroko Oka
Reviewing doctor

Hiroko OkaDirector, Hiro Clinic Kawaguchi (physician)

Japanese Society of Internal Medicine About our medical review and editorial policy

You may also like

Back to all articles

Ask our AI chat AI chat